Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Appel

Showing results (261-270 of 455) with videos related to

Pageof 46
Sort By:
HNO|May 3, 2024
[Chronic rhinosinusitis with nasal polyposis : A retrospective analysis of therapeutic approaches in 463 patients]J Strauss, R Lochbaum, T K Hoffmann, et al.
Journal of Inorganic Biochemistry|December 1, 1987
TDPAC studies of the metal-binding sites in serum transferrin: comparison between 181Hf-labeled human- and rat-serum transferrinH Appel, J Duffield, D M Taylor, et al.
Neuroscience Letters|March 8, 2000
Pramipexole inhibits lipid peroxidation and reduces injury in the substantia nigra induced by the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57BL/6 miceL Zou, J Xu, J Jankovic, et al.
Archives of Neurology|February 20, 1999
Effects of cerebrospinal fluid from patients with Parkinson disease on dopaminergic cellsW D Le, D B Rowe, J Jankovic, et al.
Synapse (New York, N.Y.)|July 1, 1995
Antibodies to calcium channels from ALS patients passively transferred to mice selectively increase intracellular calcium and induce ultrastructural changes in motoneuronsJ I Engelhardt, L Siklós, L Kömüves, et al.
Lancet (London, England)|August 3, 1996
Apolipoprotein E epsilon 4 in bulbar-onset motor neuron diseaseR G Smith, L J Haverkamp, S Case, et al.
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases|June 19, 2004
Major stressors facing patients with amyotrophic lateral sclerosis (ALS): a survey to identify their concerns and to compare with those of their caregiversMarilyn Trail, Naomi Nelson, John N Van, et al.
European Journal of Biochemistry|June 1, 1997
Comparative in-vivo and in-vitro 99Mo-time-differential-perturbed-angular-correlation studies on the nitrogenase MoFe protein and on other Mo species of different N2-fixing bacteriaA Muller, W Suer, C Pohlmann, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 24, 2008
CD4+ T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALSDavid R Beers, Jenny S Henkel, Weihua Zhao, et al.
Neurobiology of Disease|July 24, 2012
Regulatory T lymphocytes from ALS mice suppress microglia and effector T lymphocytes through different cytokine-mediated mechanismsWeihua Zhao, David R Beers, Bing Liao, et al.
Pageof 46

Showing results (261-270 of 455) with videos related to

Sort By:
Pageof 46
HNO|May 3, 2024
[Chronic rhinosinusitis with nasal polyposis : A retrospective analysis of therapeutic approaches in 463 patients]J Strauss, R Lochbaum, T K Hoffmann, et al.
Journal of Inorganic Biochemistry|December 1, 1987
TDPAC studies of the metal-binding sites in serum transferrin: comparison between 181Hf-labeled human- and rat-serum transferrinH Appel, J Duffield, D M Taylor, et al.
Neuroscience Letters|March 8, 2000
Pramipexole inhibits lipid peroxidation and reduces injury in the substantia nigra induced by the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57BL/6 miceL Zou, J Xu, J Jankovic, et al.
Archives of Neurology|February 20, 1999
Effects of cerebrospinal fluid from patients with Parkinson disease on dopaminergic cellsW D Le, D B Rowe, J Jankovic, et al.
Synapse (New York, N.Y.)|July 1, 1995
Antibodies to calcium channels from ALS patients passively transferred to mice selectively increase intracellular calcium and induce ultrastructural changes in motoneuronsJ I Engelhardt, L Siklós, L Kömüves, et al.
Lancet (London, England)|August 3, 1996
Apolipoprotein E epsilon 4 in bulbar-onset motor neuron diseaseR G Smith, L J Haverkamp, S Case, et al.
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases|June 19, 2004
Major stressors facing patients with amyotrophic lateral sclerosis (ALS): a survey to identify their concerns and to compare with those of their caregiversMarilyn Trail, Naomi Nelson, John N Van, et al.
European Journal of Biochemistry|June 1, 1997
Comparative in-vivo and in-vitro 99Mo-time-differential-perturbed-angular-correlation studies on the nitrogenase MoFe protein and on other Mo species of different N2-fixing bacteriaA Muller, W Suer, C Pohlmann, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 24, 2008
CD4+ T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALSDavid R Beers, Jenny S Henkel, Weihua Zhao, et al.
Neurobiology of Disease|July 24, 2012
Regulatory T lymphocytes from ALS mice suppress microglia and effector T lymphocytes through different cytokine-mediated mechanismsWeihua Zhao, David R Beers, Bing Liao, et al.
Pageof 46